Nerys Frances Woolacott

Search results

• 2019

  Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

  Claxton, L., O'Connor, J., Woolacott, N., Wright, K. & Hodgson, R., 1 May 2019, In: PharmacoEconomics. 37, 5, p. 645-654 10 p.

  Research output: Contribution to journal › Review article › peer-review

• Cerliponase alfa for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)

  Walton, M. J., O'Connor, J., Meader, N., Claxton, L., Harden, M., Woolacott, N. F. & Hodgson, R., 27 Nov 2019, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant

  Hodgson, R., O'Connor, J., Walton, M. J., Biswas, M. & Woolacott, N. F., 31 Jul 2019, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Strimvelis for treating severe combined immunodeficiency caused by adenosine deaminase deficiency: an evidence review group perspective of a NICE Highly Specialised Technology evaluation

  South, E., Cox, E. M., Meader, N., Woolacott, N. F. & Griffin, S., Jun 2019, In: PharmacoEconomics - Open. 3, 2, p. 151-161 11 p.

  Research output: Contribution to journal › Review article

  Open Access

  File
• 2018

  Brain and spinal stimulation therapies for phantom limb pain: a systematic review

  Corbett, M., South, E., Harden, M., Eldabe, S., Pereira, E., Sedki, I., Hall, N. & Woolacott, N., Nov 2018, In: Health technology assessment. 22, 62, p. 1-93 93 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Ceritinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

  Claxton, L., Woolacott, N. F., O'Connor, J., Wright, K. & Hodgson, R., 24 Jan 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

  Dickson, R., Boland, A., Duarte, R., Kotas, E., Woolacott, N., Hodgson, R., Riemsma, R., Grimm, S., Ramaekers, B. L. T., Joore, M. A., Büyükkaramikli, N., Kaltenthaler, E., Stevenson, M., Pandor, A., Edwards, S., Hoyle, M., Shepherd, J., Armoiry, X. & Brazzelli, M., Aug 2018, In: Applied Health Economics and Health Policy. 16, 4, p. 429-432 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Hyperhidrosis Quality of Life Measures: Review and Patient Perspective

  Wade, R. F., Jones-Diette, J. S., Wright, K., Layton, A. & Woolacott, N. F., 12 Sept 2018, In: Journal of Dermatological Treatment.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Interventional Management of Hyperhidrosis in Secondary Care: A Systematic Review

  Wade, R., Llewellyn, A., Jones-Diette, J., Wright, K., Rice, S., Layton, A. M., Levell, N. J., Craig, D. & Woolacott, N., 17 Sept 2018, In: British Journal of Dermatology. 179, 3, p. 599-608 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Midostaurin for untreated acute myeloid leukaemia

  Hodgson, R., Biswas, M., Mebrahtu, T., Morgan, P. J., Harden, M. & Woolacott, N. F., 13 Jun 2018, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2017

  Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation

  Duarte, A., Mebrahtu, T., Goncalves, P. S., Harden, M., Murphy, R., Palmer, S., Woolacott, N., Rodgers, M. & Rothery, C., 6 Nov 2017, In: Health technology assessment. 21, 64, p. 1-280 280 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• A Review of Ruxolitinib for the Treatment of Myelofibrosis: A Critique of the Evidence

  Wade, R. F., Hodgson, R., Biswas, M., Harden, M. & Woolacott, N. F., Feb 2017, In: PharmacoEconomics. 35, 2, p. 203-213 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation

  Corbett, M., Chehadah, F., Biswas, M., Moe-Byrne, T., Palmer, S., Soares, M., Walton, M., Harden, M., Ho, P., Woolacott, N. & Bojke, L., 5 Oct 2017, In: Health technology assessment. 21, 56, p. 1-326 326 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

  Morgan, P. J., Woolacott, N. F., Biswas, M., Mebrahtu, T., Harden, M. & Hodgson, R., 24 Mar 2017, (E-pub ahead of print) In: PharmacoEconomics. p. 1-11 12 p.

  Research output: Contribution to journal › Review article

  Open Access

  File

• Diagnosis of childhood obesity using BMI: potential ethicolegal implications and downstream effects: a response

  Simmonds, M., Llewellyn, A., Owen, C. G. & Woolacott, N., 1 Mar 2017, In: Obesity reviews. 18, 3, p. 382-383 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Eliglustat for treating type 1 Gaucher disease

  Hodgson, R., Morgan, P. J., Yang, H., Hodkinson, A., Harden, M. & Woolacott, N. F., 28 Jun 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Etirinotecan pegol for treating breast cancer with brain metastases

  Claxton, L., Wade, R., Sharif, S., Harden, M., Woolacott, N. F. & Hodgson, R., 11 Jul 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Innovative regenerative medicines in the EU: a better future in evidence?

  Corbett, M. S., Woolacott, N. F., Webster, A. J. & Hawkins, R., 2017, In: BMC Medicine. 15, 49

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis

  Wade, R., Rice, S., Llewellyn, A., Moloney, E., Jones-Diette, J., Stoniute, J., Wright, K., Layton, A. M., Levell, N. J., Stansby, G., Craig, D. & Woolacott, N., 1 Dec 2017, In: Health technology assessment. 21, 80, p. 1-280 280 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Methodological challenges identified for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview

  Woolacott, N., Corbett, M., Jones-Diette, J. & Hodgson, R., 12 Jul 2017, (E-pub ahead of print) In: Journal of Clinical Epidemiology. p. 1-25 25 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Surgical patients' adherence to the use of compression stockings

  Wade, R. F., Paton, F. & Woolacott, N. F., 20 Mar 2017, In: Nursing Times. 113, 4, p. 32-33 2 p.

  Research output: Contribution to journal › Article

• Systematic review of patient preference and adherence to the correct use of graduated compression stockings to prevent deep vein thrombosis in surgical patients

  Wade, R. F. & Woolacott, N. F., 9 Jan 2017, In: Journal of Advanced Nursing. 73, 2, p. 336-348 28 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal

  Hettle, R., Corbett, M., Hinde, S., Hodgson, R., Jones-Diette, J., Woolacott, N. & Palmer, S., 1 Mar 2017, In: Health technology assessment. 21, 7, p. 1-204 205 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process

  Carroll, C., Kaltenthaler, E., Hill-McManus, D., Scope, A., Holmes, M., Rice, S., Rose, M., Tappenden, P. & Woolacott, N., Jun 2017, In: Value in Health. 20, 6, p. 785-791 7 p.

  Research output: Contribution to journal › Article › peer-review

• Ustekinumab for treating moderately to severely active CD after prior therapy

  Hodgson, R., Biswas, M., Mebrahtu, T., Walton, M. J., Harden, M. & Woolacott, N. F., 12 Jul 2017, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

  Hodgson, R., Walton, M., Biswas, M., Mebrahtu, T. & Woolacott, N., 30 Nov 2017, (E-pub ahead of print) In: PharmacoEconomics. p. 1-12 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File
• 2016

  Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence

  Hinde, S., Wade, R., Palmer, S., Woolacott, N. & Spackman, E., 2016, In: PharmacoEconomics. 34, 6, p. 587–596 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Childhood obesity as a predictor of morbidity in adulthood: a systematic review and meta-analysis

  Llewellyn, A., Simmonds, M., Owen, C. G. & Woolacott, N., Jan 2016, In: Obesity reviews. 17, 1, p. 56-67 12 p.

  Research output: Contribution to journal › Article › peer-review

• Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer

  Hodgson, R., Biswas, M., Morgan, P. J., Mebrahtu, T., Harden, M. & Woolacott, N. F., 28 Sept 2016, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence

  Llewellyn, A., Faria, R., Woods, B., Simmonds, M., Lomas, J., Woolacott, N. & Griffin, S., 8 Jun 2016, (E-pub ahead of print) In: PharmacoEconomics. p. 1-12 12 p.

  Research output: Contribution to journal › Article › peer-review

• Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process

  Kaltenthaler, E., Carroll, C., Hill-McManus, D., Scope, A., Holmes, M., Rice, S., Rose, M., Tappenden, P. & Woolacott, N., 4 Nov 2016, In: PharmacoEconomics - Open. 1, 2, p. 99-108 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Predicting adult obesity from childhood obesity: A systematic review and meta-analysis

  Simmonds, M., Llewellyn, A., Owen, C. G. & Woolacott, N., 1 Feb 2016, In: Obesity reviews. 17, 2, p. 95-107 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Ruxolitinib for disease-related splenomegaly or symptoms in adults with myelofibrosis (review of TA289)

  Hodgson, R., Wade, R., Biswas, M., Harden, M. & Woolacott, N. F., 23 Mar 2016, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Simple tests for the diagnosis of childhood obesity: A systematic review and meta-analysis

  Simmonds, M., Llewellyn, A., Owen, C. G. & Woolacott, N., 19 Oct 2016, (E-pub ahead of print) In: Obesity reviews. 61, p. 46-60 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence

  Sideris, E., Corbett, M. S., Palmer, S. J., Woolacott, N. F. & Bojke, L., 8 Jun 2016, (E-pub ahead of print) In: Pharmacoeconomics.. 34, 11, p. 1101–1110 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the Evidence

  O'Connor, J., Rice, S., Smith, A., Rodgers, M., Lopez, R. R., Craig, D. & Woolacott, N., Apr 2016, In: PharmacoEconomics. 34, 4, p. 337-348 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis

  Kaltenthaler, E., Carroll, C., Hill-McManus, D., Scope, A., Holmes, M., Rice, S., Rose, M., Tappenden, P. & Woolacott, N., Apr 2016, In: Health technology assessment. 20, 26, p. 1-48 48 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Thigh length versus knee length antiembolism stockings for the prevention of deep vein thrombosis in postoperative surgical patients; a systematic review and network meta-analysis

  Wade, R., Paton, F., Rice, S., Stansby, G., Millner, P., Flavell, H., Fox, D. & Woolacott, N., 16 Feb 2016, In: BMJ Open. 6, 2, 10 p., e009456.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

• Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation

  Corbett, M., Soares, M., Jhuti, G., Rice, S., Spackman, E., Sideris, E., Moe-Byrne, T., Fox, D., Marzo-Ortega, H., Kay, L., Woolacott, N. & Palmer, S., Feb 2016, In: Health technology assessment. 20, 9, p. 1-334 334 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File
• 2015

  Dinutuximab for treating high-risk neuroblastoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

  Saramago Goncalves, P. R., Simmonds, M. C., Biswas, M., Wright, K., Woolacott, N. F. & Rothery, C., 2015, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Evidence Review Group's Report: Daclatasvir for treating chronic hepatitis C. Report to NICE.

  Woods, B., Llewellyn, A., Faria, R., Lomas, J., Harden, M., Woolacott, N. F. & Griffin, S., 2015, NICE. 230 p.

  Research output: Book/Report › Commissioned report

• Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis

  Wade, R., Sideris, E., Paton, F., Rice, S., Palmer, S., Fox, D., Woolacott, N. & Spackman, E., Nov 2015, In: Health technology assessment. 19, 98, p. 1-220 220 p.

  Research output: Contribution to journal › Article › peer-review

• The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence

  Wade, R., Duarte, A., Simmonds, M., Rodriguez-Lopez, R., Duffy, S., Woolacott, N. & Spackman, E., 24 Jan 2015, In: PharmacoEconomics. 33, 5, p. 457-466 10 p.

  Research output: Contribution to journal › Article › peer-review

• The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: A systematic review and meta-analysis

  Simmonds, M., Burch, J., Llewellyn, A., Griffiths, C., Yang, H., Owen, C., Duffy, S. & Woolacott, N., Jun 2015, In: Health technology assessment. 19, 43, p. 1-336 336 p.

  Research output: Contribution to journal › Article › peer-review
• 2014

  Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool

  Corbett, M. S., Higgins, J. P. T. & Woolacott, N. F., Mar 2014, In: Research Synthesis Methods. 5, 1, p. 79-85 7 p.

  Research output: Contribution to journal › Article › peer-review

• Response to letter to the Editor: Comment on Corbett et al. entitled "Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis"

  Corbett, M. S., Rice, S. J. C., Madurasinghe, V. & Woolacott, N. F., May 2014, In: Osteoarthritis and cartilage. 22, 5, p. 712-713 2 p.

  Research output: Contribution to journal › Letter › peer-review

• The added clinical and economic value of diagnostic testing for epilepsy surgery

  Hinde, S., Soares, M., Burch, J., Marson, A., Woolacott, N. & Palmer, S., 19 Feb 2014, In: Epilepsy research. 108, 4, p. 775-781 7 p.

  Research output: Contribution to journal › Article › peer-review
• 2013

  Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis

  Corbett, M. S., Rice, S. J. C., Madurasinghe, V., Slack, R., Fayter, D. A., Harden, M., Sutton, A. J., Macpherson, H. & Woolacott, N. F., Sept 2013, In: Osteoarthritis and cartilage. 21, 9, p. 1290-8 9 p.

  Research output: Contribution to journal › Article › peer-review

• Aflibercept in combination with irinotecan and fluorouracil-based therapy for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy: A Single Technology Appraisal.

  Wade, R., Duarte, A. I., Simmonds, M. C., Rodriguez-Lopez, R., Duffy, S., Spackman, E. & Woolacott, N. F., 2013, NICE.

  Research output: Book/Report › Commissioned report

• A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system

  Wade, R., Yang, H., McKenna, C., Faria, R., Gummerson, N. & Woolacott, N., 2013, In: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 22, 2, p. 296-304

  Research output: Contribution to journal › Article › peer-review